Willingness to Use Long-acting Injectable Pre-exposure Prophylaxis Among Key Populations at a Large Hiv Prevention Clinic in Kampala, Uganda: a Cross-sectional Study

Author:

Lukubuya Jonathan Derrick1,Katana Elizabeth B.2,Baguma Micheal1,Kaguta Andrew1,Nambatya Winnie1,Kyambadde Peter3,Muwonge Timothy R.4,Mujugira Andrew4,Odongpiny Eva Agnes Laker4

Affiliation:

1. School of Pharmacy, College of Health Sciences, Makerere University

2. Uganda National Institute of Public Health, Ministry of Health

3. Most At Risk Populations Initiative (MARPI), Mulago National Referral Hospital

4. The Infectious Diseases Institute, College of Health Sciences, Makerere University

Abstract

Abstract

Background. Long-acting injectable (LAI)-PrEP provides better protection against HIV compared to oral PrEP, which requires taking a daily pill. Our study aimed to assess knowledge about oral and LAI-PrEP and identify factors associated with willingness to use LAI-PrEP among key populations (KP) in Uganda. Methods. We conducted a cross-sectional study at the Most at Risk Populations Initiative (MARPI) clinic between November and December 2021. Participants were recruited through convenience sampling and interviewed using a structured questionnaire by trained interviewers. Participants were categorised into three groups based on their oral PrEP use: those who had not yet initiated PrEP, those who had discontinued oral PrEP, and those currently on oral PrEP. Modified Poisson regression analysis was performed to determine factors associated with the participant's willingness to use LAI-PrEP. Data was analysed using STATA 14 software. Results. Of the 234 participants, 135 (56.7%) were female, 82.5% knew about LAI-PrEP, and 67.5% were willing to use it. The mean age was 28.7 years (standard deviation [SD] 5.8). Willingness to use LAI-PrEP was less likely among divorced, widowed, or separated individuals than those in relationships (adjusted prevalence ratio [aPR] 0.65, 95% CI: 0.43–0.98). Relative to current oral PrEP users, willingness to use LAI-PrEP was similar among those who discontinued oral PrEP (aPR 1.39, 95% CI: 0.92–2.11) and those who had not yet initiated PrEP but were at risk for HIV (aPR 1.26, 95% CI: 0.83–1.89). Conclusions. In this cross-sectional analysis of diverse members of key populations in Uganda, previous or non-use of oral PrEP was not associated with willingness to use LAI-PrEP relative to current users. Future studies should investigate effective methods for promoting the uptake of long-acting PrEP formulations among populations at high risk of HIV acquisition.

Publisher

Springer Science and Business Media LLC

Reference30 articles.

1. UNAIDS, Global HIV. & AIDS statistics — Fact sheet 2023 [updated 31st August, 20238th October, 2023]. https://www.unaids.org/en/resources/fact-sheet#:~:text=In%202022%2C%20there%20were%2039.0%20million%20%5B33.1%20million%E2%80%9345.7,people%20living%20with%20HIV%20were%20women%20and%20girls.

2. Poku O, INTERSECTING, VULNERABILITIES:, THE IMPLICATIONS OF DISCLOSURE, STIGMA, AND MENTAL HEALTH FOR INDIVIDUALS LIVING WITH HIV IN SUB-SAHARAN AFRICA. Johns Hopkins University; 2021.

3. HIV Infection and AIDS in Sub-Saharan Africa: Current Status, Challenges and Opportunities;Kharsany ABM;Open AIDS J,2016

4. Street C, World Aids. Day 2022 2022 [ https://coinstreet.org/latest/world-aids-day-2022.

5. UAC. The 2023 Joint AIDS Review Report. In: President Oot, editor.; 2023.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3